To test the behavior of genes whose expression was influenced by changes in YAP1 expression in vivo, the levels of MAP2K5, PTPN11, SPB1, and PPM1A mRNA were determined in HCC prognostic subgroups. The gene discussed is MAP2K5; the disease is hepatocellular carcinoma.